Prodotti competitors / Area Kite
Nerviano Medical Sciences Announces FDA Clearance of Investigational New Drug (IND) for NMS-03592088 in positive r/r AML
![Immagine News](/media/l4el5htd/cat-2.jpg?anchor=center&mode=crop&width=722&height=442)
Nerviano Medical Sciences Announces FDA Clearance of Investigational New Drug (IND) for NMS-03592088 ((NMS-088), a novel, potent FLT3 inhibitor) in positive Relapsed or Refractory Acute Myeloid Leukemia.
Grazie per il tuo feedback!